| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000087814 |
| P698 | PubMed publication ID | 16118508 |
| P2093 | author name string | Stefano Cordio | |
| Luigi Manzione | |||
| Gerardo Rosati | |||
| Aniello Tucci | |||
| Giorgio Reggiardo | |||
| Roberto Bordonaro | |||
| Giuseppina Blanco | |||
| P2860 | cites work | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 |
| XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer | Q33978749 | ||
| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. | Q34282412 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. | Q34754672 | ||
| Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer | Q43658197 | ||
| Optimal two-stage designs for phase II clinical trials | Q46412217 | ||
| P433 | issue | 2 | |
| P921 | main subject | colorectal cancer | Q188874 |
| oxaliplatin | Q422327 | ||
| colorectal carcinoma | Q25493920 | ||
| phase II clinical trial | Q42824440 | ||
| metastatic colon cancer | Q108566365 | ||
| P304 | page(s) | 122-129 | |
| P577 | publication date | 2005-08-23 | |
| P1433 | published in | Oncology | Q2016300 |
| P1476 | title | Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients | |
| P478 | volume | 69 |
| Q36365078 | 'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer' |
| Q36858220 | Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer |
| Q35097975 | Effects of bolus injection of 5-fluorouracil on steady-state plasma concentrations of 5-fluorouracil in Japanese patients with advanced colorectal cancer |
| Q36299980 | Elderly patients with advanced colorectal cancer: which therapy is the safest? |
| Q33918152 | First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study. |
| Q37411495 | Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy |
| Q36318341 | Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer |
| Q64110215 | Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials |
| Q37113563 | Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer |
| Q34982764 | Systemic therapy for elderly patients with gastrointestinal cancer. |
| Q38059634 | Systemic treatment of gastrointestinal cancer in elderly patients |
| Q37298994 | Treatment of the elderly colorectal cancer patient: SIOG expert recommendations |
Search more.